Ghrelin, a peptide hormone predominantly synthesized in the stomach, has emerged as a significant regulator of various physiological processes. Initially identified as a growth hormone (GH)-releasing peptide, ghrelin's role extends beyond its endocrine function in GH regulation. It has been implicated in a myriad of actions, including energy homeostasis, gastric functions, and even cognitive behaviors. This comprehensive analysis will delve into the multifaceted nature of ghrelin, exploring its mechanisms of action and its diverse applications in different fields.
Ghrelin's mechanism of action is complex and involves interactions with various receptors and physiological systems. It has been shown to induce vasorelaxation through GH-independent mechanisms, improving endothelial dysfunction by increasing endothelial nitric oxide synthase (eNOS) expression in GH-deficient rats1. In the central nervous system, ghrelin targets neurons in the hypothalamus, stimulating the release of orexigenic peptides and neurotransmitters, thereby regulating energy homeostasis3. Ghrelin also interacts directly with neuropeptide-Y (NPY)-containing neurons in the arcuate nucleus, inducing calcium signaling via protein kinase A and N-type channel-dependent mechanisms6. Furthermore, ghrelin's role in gastric functions is mediated through vagal pathways, enhancing gastric acid secretion and motility4. It also influences insulin secretion by increasing cytosolic free Ca²⁺ concentration in pancreatic beta-cells10.
Ghrelin has been shown to induce adiposity in rodents by reducing fat utilization and increasing food intake through its action on the hypothalamus and pituitary axis2. Chronic central infusion of ghrelin increases hypothalamic neuropeptide Y and Agouti-related protein mRNA levels, leading to weight gain in rats without affecting plasma insulin, glucose, leptin, or GH concentrations5. These findings suggest ghrelin's potential role in the development of therapeutic strategies for metabolic disorders.
The peptide's ability to improve endothelial dysfunction presents a potential therapeutic application in cardiovascular diseases. By increasing eNOS expression and enhancing vasorelaxation, ghrelin could be beneficial in conditions characterized by endothelial dysfunction1.
Ghrelin's stimulatory effects on gastric acid secretion and motility highlight its significance in gastrointestinal health4. It may play a physiological role in the vagal control of gastric functions, and its interaction with nitric oxide suggests a complex regulatory mechanism8.
Interestingly, ghrelin has been found to influence cognitive behaviors, such as anxiety and memory retention in rats9. This suggests that ghrelin and its receptors could be targets for developing treatments for neuropsychiatric conditions or cognitive enhancement therapies.
The presence of ghrelin in pancreatic alpha-cells and its stimulatory effect on insulin secretion indicate its involvement in glucose homeostasis and potential implications for diabetes management10.
CAS No.: 32426-57-6
CAS No.: 163000-63-3
CAS No.: 103025-21-4
CAS No.:
CAS No.: 141-81-1